"Botoxins" Neuromodulation: Evolution of Anatomy, Strategies and the Future 2024

In this presentation on neuromodulation and Botox, the speaker highlights the history and evolution of botulinum toxins, beginning with Alan Scott's groundbreaking work that turned a toxic molecule into a billion-dollar treatment. The discussion includes insights into the therapeutic applications for conditions like blepharospasm and facial aesthetics, while emphasizing the importance of proper dosing and treatment strategies. Topics covered include the anatomical considerations of facial muscles, the effects of neuromodulators on brow positioning, as well as results from clinical studies comparing different botulinum products, including Botox and Dysport. The findings indicate that higher doses can prolong treatment effects, supporting the mantra that brow position is more important than eliminating lines. Additionally, the emergence of new products like Daxify and Bonti is noted, offering insights into alternatives with varying efficacy and application timelines. Ultimately, there's a call for a new terminology to better reflect the therapeutic nature of these agents, rather than referring to them as 'toxins.' The speaker concludes with a strong endorsement for further research into dosing strategies and the future of neuromodulators in clinical practices.